Clorox (NYSE:CLX) Price Target Lowered to $142.00 at Wells Fargo & Company

Clorox (NYSE:CLX - Get Free Report) had its target price reduced by investment analysts at Wells Fargo & Company from $145.00 to $142.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an "equal weight" rating on the stock. Wells Fargo & Company's target price would indicate a potential upside of 2.64% from the company's current price.

Several other equities analysts have also issued reports on CLX. DA Davidson cut their price objective on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. JPMorgan Chase & Co. reduced their target price on Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a research note on Tuesday. Barclays dropped their price objective on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating on the stock in a report on Friday, April 11th. UBS Group dropped their target price on Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a report on Thursday, April 17th. Finally, Citigroup decreased their price objective on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research report on Monday, April 14th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $153.00.

Clorox Trading Down 0.5 %

NYSE:CLX opened at $138.35 on Tuesday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The business has a fifty day moving average price of $143.85 and a 200-day moving average price of $154.69. The firm has a market capitalization of $17.04 billion, a price-to-earnings ratio of 37.80, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. Clorox has a one year low of $127.60 and a one year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). The firm had revenue of $1.67 billion for the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The firm's revenue was down 8.0% on a year-over-year basis. During the same period last year, the company earned $1.71 earnings per share. Sell-side analysts forecast that Clorox will post 7.15 EPS for the current year.

Hedge Funds Weigh In On Clorox

Several large investors have recently modified their holdings of the stock. Norges Bank bought a new position in Clorox in the 4th quarter worth about $259,041,000. FMR LLC lifted its holdings in Clorox by 75.4% in the 4th quarter. FMR LLC now owns 1,361,758 shares of the company's stock valued at $221,163,000 after acquiring an additional 585,526 shares during the last quarter. KBC Group NV lifted its position in shares of Clorox by 688.7% during the 1st quarter. KBC Group NV now owns 587,679 shares of the company's stock valued at $86,535,000 after acquiring an additional 513,171 shares during the last quarter. Marshall Wace LLP raised its position in shares of Clorox by 549.8% during the fourth quarter. Marshall Wace LLP now owns 542,726 shares of the company's stock worth $88,144,000 after purchasing an additional 459,203 shares during the period. Finally, ExodusPoint Capital Management LP lifted its stake in Clorox by 187.9% during the fourth quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company's stock valued at $113,508,000 after buying an additional 456,114 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.